-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

802.O1.6 802. Chemical Biology and Experimental Therapeutics

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Fundamental Science, Translational Research, Therapies, Technology and Procedures
Saturday, December 11, 2021: 2:00 PM-3:30 PM
C108-C109, Level 1, Building C (Georgia World Congress Center)
and Joanna S. Yi, MD, Texas Children's Hospital
No relevant conflicts of interest to declare.
2:00 PM

Francesco Di Meo1*, Christina Yu1*, Annamaria Cesarano1*, Aljoufi Arafat2*, Silvia Marino, PhD1, G David Roodman, MD, PhD1, Hal E. Broxmeyer, PhD2 and Fabiana Perna, MD, PhD1

1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
2Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN

2:15 PM

Shan Lin, PhD1,2, Clement Larrue3*, Nastassja K. Scheidegger1*, Bo Kyung A. Seong1*, Neekesh V Dharia, MD, PhD1,2*, Caroline Wechsler1*, Guillaume Kugener2*, Amanda L Robinchaud1*, Amy Conway1*, Biniam Adane1*, Scott Younger, PhD2,4*, Federica Piccioni, PhD2*, Lynn Lee5*, Mark Wunderlich, MS6*, Jerome Tamburini3* and Kimberly Stegmaier, MD1,2

1Dana-Farber Cancer Institute, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA
3Translational Research Centre In Onco-Hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
4Children's Mercy Kansas City, Children's Mercy Research Institute, Kansas City, MO
5Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
6Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

2:30 PM

Sylvain Garciaz1,2,3*, Sebastian Müller4*, Andrew Guirguis2*, Fiona C. Brown5,6*, Yih-Chih Chan2*, Mathilde Poplineau1,7, Kevin Tran2*, Kah-Lok Chan2*, Laura MacPherson2*, Brian Liddicoat2*, Enid Y. N. Lam2*, Tatiana Cañeque4*, Marian L. Burr2*, Veronique Litalien6*, Giovanna Pomilio8*, Estelle Duprez9*, David C.S. Huang, MBBS, PhD10*, Sarah-Jane Dawson11*, Georg Ramm12*, Andrew G. Cox2*, Kristin K. Brown2*, Andrew H. Wei, MBBS, PhD13, Kate McArthur14*, Raphael Rodriguez4* and Mark A. Dawson2

1Institut Paoli-Calmettes, CRCM, Marseille, France
2Peter MacCallum Cancer Centre, Melbourne, Australia
3Institut Paoli Calmettes, Institut Paoli-Calmettes, Marseille, France
4Institut Curie, Paris, France
5Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia
6Monash University, Australian Centre for Blood Diseases, Melbourne, Australia
7CRCM, Marseille, France
8Australian Centre for Blood Diseases, Melbourne, Australia
9Centre de Recherche en Cancérologie de Marseille, Marseille, France
10The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
11Peter Maccallum Cancer Centre, Melbourne, Australia
12Monash University, Melbourne, Australia
13The Alfred Hospital and Monash University, Melbourne, Australia
14Monash University, Clayton, Australia

2:45 PM

Vivian G. Oehler, MD1,2, Sylvia Chien, MS3*, Jin Dai, PhD3*, Carrie L. Cummings2*, James Annis4*, Timothy J Martins, PhD4* and Pamela S. Becker, MD, PhD1,5

1Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Department of Medicine, University of Washington, Seattle, WA
4Institute for Stem Cell and Regenerative Medicine/Department of Medicine, University of Washington, Seattle, WA
5Division of Hematology/Oncology, University of California, Irvine, Irvine, CA

3:00 PM

Madhav R Seshadri, MD1, Lorena Fontan, PhD1, Prasanna Sreevatsan, PhD2,3*, David Scott, PhD2,3*, John Hatcher, PhD2,3*, Guangyan Du, PhD2,3*, Min Xia, PhD1, Ilkay Us1*, Nathanael Gray, PhD2,3* and Ari Melnick, MD1

1Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
2Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA
3Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA

3:15 PM

Steven Sher1,2*, Larry Beaver, BS3*, Katie Williams, MS3*, Shelley Orwick, B.S.3*, Brandi R. Walker, BS3*, Charles Thomas Gregory, BS3*, Matthew Purcell, BS3*, Alexander Pan, BS4*, Pearlly S. Yan, PhD4*, Amy J. Johnson, PhD5, Melanie M. Frigault, PhD5, Joy M. Greer5*, Ahmed Hamdy, MD5, Raquel Izumi, PhD5, Stuart Hwang, PhD5*, James S. Blachly, MD3, John C. Byrd, MD5,6 and Rosa Lapalombella, PhD3

1Division of Hematology, Department of Internal Medicine, THE OHIO STATE UNIVERSITY, COLUMBUS, OH
2Medical Scientist Training Program, The Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4The Ohio State University, Columbus, OH
5Vincerx Pharma Inc, Palo Alto, CA
6Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

*signifies non-member of ASH